Menopause Completed Phase 2 Trials for Tibolone (DB09070)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00165204Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic OophorectomyTreatment